Oura and Counsel Health Expand Partnership Through CMS ACCESS Model

The landscape of modern healthcare is undergoing a profound structural shift, marked by the increasing convergence of consumer wearable technology, artificial intelligence, and traditional clinical practice. In a major development announced today, smart-ring pioneer Oura has entered a new phase of its strategic partnership with Counsel, an AI-native primary care provider. This expanded collaboration is designed to leverage the Centers for Medicare & Medicaid Services (CMS) Innovation Center’s Advancing Chronic Care with Effective Scalable Solutions (ACCESS) Model. By integrating continuous biometric monitoring with physician-led care on an unprecedented scale, the initiative aims to transform how chronic health conditions are managed among vulnerable and aging populations.

Beginning in early 2027, Counsel will roll out specialized, AI-native chronic care programs targeting some of the most prevalent and costly public health challenges in the United States, including hypertension, obesity, hyperlipidemia, and prediabetes. Crucially, these comprehensive services will be provided at no out-of-pocket cost to eligible Medicare beneficiaries across nearly all U.S. states. The program represents a landmark effort to test whether the combination of passive health tracking and responsive telemedicine can meaningfully improve clinical outcomes, reduce emergency interventions, and ease the operational strain on the traditional Medicare infrastructure.

Chronology of the Partnership and the Evolution of Care

To understand the significance of the new CMS ACCESS initiative, it is essential to examine the trajectory of the collaboration between Oura and Counsel. The partnership officially commenced in May, when the two companies joined forces to bridge a longstanding gap in digital health: the transition from passive health data collection to actionable clinical intervention. Historically, consumer wearables have excelled at generating deep reservoirs of personal health metrics—ranging from resting heart rate and heart rate variability to sleep stages and temperature trends—while leaving the interpretation and clinical follow-up entirely up to the user.

The initial integration sought to remedy this fragmentation. By connecting the Oura App with Counsel’s platform, Oura members were given a direct pathway from everyday health insights to on-demand access to board-certified physicians and advanced medical AI. This early iteration proved remarkably successful. In the months following the launch, early data revealed high user satisfaction, with members who consulted a physician rating their care experience an impressive 4.6 out of 5. Users consistently highlighted the convenience, clarity, and quality of the combined service, noting that it eliminated much of the confusion traditionally associated with interpreting raw biometric data.

Building upon this foundational success, the current expansion under the CMS ACCESS Model scales the concept from a consumer-facing wellness integration to a formalized, federally recognized healthcare delivery study. Rather than operating strictly within the realm of elective wellness, Oura and Counsel are now positioned to evaluate their integrated care model within a rigorous clinical framework designed for government-insured populations living with diagnosed chronic illnesses.

Demographics, Data, and the Case for Targeted Chronic Care

The decision to focus the ACCESS rollout on hypertension, obesity, hyperlipidemia, and prediabetes is rooted in rigorous public health data. Chronic conditions account for the vast majority of healthcare expenditures in the United States, and Medicare beneficiaries are disproportionately affected by these complex, interrelated diseases. Addressing cardio-kidney-metabolic disorders requires continuous vigilance, lifestyle modification, and timely clinical intervention—elements that traditional episodic healthcare struggles to provide efficiently.

Interestingly, demographic data from Oura’s existing user base reveals a strong natural alignment with the target audience of the ACCESS program. Individuals aged 65 and older represent one of the most engaged segments of Oura’s membership, exhibiting exceptionally high rates of daily app usage and sustained interaction with their biometric dashboards. Furthermore, internal data indicates that approximately 20% of Oura members within this senior demographic present with a Body Mass Index (BMI) of 30 or higher, placing them in the clinical category of obesity and elevating their risk for downstream cardiovascular and metabolic complications.

This intersection of high daily engagement and elevated clinical risk underscores why continuous biometric monitoring holds such transformative potential for older adults. Unlike traditional point-in-time clinical measurements—such as a blood pressure reading taken once every six months during a routine doctor’s visit—continuous data streams provide a holistic, longitudinal view of a patient’s physiological state. When anomalous trends are detected by Oura’s sensors, Counsel’s medical AI and clinical team can intervene proactively, preventing minor physiological shifts from escalating into acute medical emergencies.

Inside the Model: Combining Medical AI with Physician-Led Care

The operational framework of the Counsel and Oura ACCESS initiative rests on a dual-layer support structure that marries computational efficiency with human clinical expertise. Under the model, eligible Medicare beneficiaries who utilize the Oura Ring and explicitly consent to share their health information will grant Counsel access to continuous biometric insights harvested directly from the Oura App.

Once integrated, Counsel’s proprietary medical AI continuously analyzes incoming data streams to identify patterns, deviations, and early warning signs associated with the patient’s specific chronic conditions. However, the system is explicitly designed to keep human physicians at the center of the decision-making process. The AI acts as a sophisticated triage and guidance engine, delivering personalized health recommendations while offering on-demand access to board-certified medical professionals. When a patient requires clinical evaluation or treatment adjustment, they can connect directly with a physician who already has full visibility into their recent continuous health history.

This seamless fusion of technology and human empathy is intended to reduce friction in the healthcare experience. For elderly patients or those managing multiple chronic conditions, navigating specialist referrals, tracking symptoms manually, and remembering medication schedules can be overwhelming. By automating the data synthesis process and delivering care directly through connected mobile interfaces, the model removes traditional logistical barriers to healthcare access.

Official Perspectives and Leadership Commentary

Industry leaders have emphasized that this partnership represents a vital evolution in value-based care. In official statements released alongside the announcement, executives from both organizations underscored the broader implications of participating in the CMS Innovation Center’s rigorous testing framework.

Dr. Ricky Bloomfield, Chief Medical Officer at Oura, highlighted the clinical ambition driving the initiative. "Earlier in the year, we partnered with Counsel to help Oura Members move from health insights to clinical action," Dr. Bloomfield stated. "The ACCESS program gives us the opportunity to study that model at scale, and to better understand how continuous biometric data, combined with physician-led care, can support Medicare beneficiaries managing hypertension, obesity, and other early cardio-kidney-metabolic conditions."

Representatives from Counsel similarly stressed that the collaboration bridges a critical gap in chronic disease management, moving the healthcare industry away from reactive treatments and toward continuous, data-driven prevention. By combining Oura’s hardware accuracy with Counsel’s AI-powered clinical workflows, the partnership aims to establish a scalable blueprint that other healthcare providers and technology companies can emulate.

Implementation, Enrollment, and the Path to 2027

As preparations for the official rollout continue, both companies are establishing clear protocols for patient onboarding and clinical eligibility verification. The operational workflow is designed to be as user-friendly as possible, utilizing the existing digital infrastructure of the Oura App to inform members about the ACCESS program.

Oura will act as an informational bridge, connecting interested members directly with Counsel. Once a member expresses interest, Counsel will independently perform rigorous clinical eligibility assessments, handle formal enrollment procedures, and assume full responsibility for managing the patient’s ongoing care plan in compliance with CMS guidelines.

Comprehensive details regarding exact enrollment procedures, eligibility criteria verification timelines, and app integration updates will be rolled out progressively through the Oura App as the early 2027 launch date approaches.

Implications for the Future of Digital Health and Medicare

The inclusion of consumer wearable technology in a federally backed CMS Innovation Center model marks a watershed moment for the digital health industry. For years, the boundary between consumer wellness devices and clinical-grade medical equipment has been gradually eroding, driven by improvements in sensor accuracy and data security. However, formal integration into the Medicare ecosystem elevates these tools from lifestyle accessories to recognized components of chronic disease management.

If the ACCESS Model successfully demonstrates that continuous biometric data can improve health outcomes while lowering the total cost of care for conditions like hypertension and obesity, the implications will extend far beyond this specific partnership. It could pave the way for broader regulatory acceptance, wider insurance reimbursement for wearable technology, and a fundamental restructuring of how primary care is delivered to an aging global population.

Ultimately, the collaboration between Oura and Counsel seeks to address a profound systemic challenge: matching the complexity of chronic disease management with a level of continuous, personalized support that meets patients where they are. As the healthcare sector looks toward 2027 and the formal launch of the ACCESS initiative, this pioneering model offers a compelling glimpse into a more connected, proactive, and patient-centric future.